Clinical Trials in Pittsburgh

Showing 2941-2960 of 21,047 trials

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

NCT05867420

The study is a dose-escalation and dose-expansion study to evaluate the safety, tolerability, and pharmacokinetics of ASKG915 as a single agent or in combination with standard of care (SOC) in patients with selected types of advanced solid tumors.

Advanced Solid Tumors

AskGene Pharma, Inc.594 participantsStarted Aug 2023

New York, New York, United States • Pittsburgh, Pennsylvania, United States • Beijing, Beijing Municipality, China +1 more locations

Active Not RecruitingPhase 377 miles

A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

NCT06311721

The primary objective of this study is to compare the efficacy of ABP 234 with the pembrolizumab reference product (Keytruda®).

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

Amgen315 participantsStarted Sep 2024

Beverly Hills, California, United States • Cerritos, California, United States • Los Alamitos, California, United States +216 more locations

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

Find Trials by Condition in Pittsburgh

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

Multicenter Orthopaedics Outcomes Network for ACL Reconstructions

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema

Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis

A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy Volunteers

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

Platform Trial Evaluating Safety and Efficacy of Ezabenlimab Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)

Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder

Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer